News

CareLineLive Attracts Major Investment for Future Growth

CareLineLive Attracts Major Investment for Future Growth

CareLineLive Attracts Major Investment for Future Growth

CareLineLive, a notable player in home care management software, has recently secured a substantial investment from Accel-KKR, a prominent technology-focused investment firm. This partnership is set to propel CareLineLive into a new phase of growth, enhancing its capabilities in product development and expansion.

Founded in 2014, CareLineLive was established by entrepreneur Josh Hough to create an integrated cloud-based platform tailored for home care agencies. The software facilitates staff scheduling, client visits, patient records, and invoicing, serving hundreds of care providers across multiple countries.

With the home healthcare market on the rise globally, CareLineLive is well-positioned to benefit. For instance, the UK's home care market is valued at approximately £11.5 billion. Similarly, the Australian market is expected to reach about USD 25.7 billion by 2030, while the U.S. home care providers market holds an estimated value of USD 153.7 billion in the near future.

Josh Hough expressed his excitement regarding the investment, stating that it would play a crucial role in accelerating the company’s growth and expanding its international footprint. Hough envisions a future where technology enhances the homecare experience for providers, carers, and clients alike. He noted the expertise of Accel-KKR as a driving factor behind the partnership's potential success.

A strategic portion of the funds will also contribute towards establishing a customer support presence in Australia, allowing for customer service to operate around the clock. As the team in the UK wraps up for the day, the Australian team will begin, ensuring clients receive support at all hours.

While the exact valuation of the deal remains undisclosed, the investment allows early backers to exit, fostering exciting new opportunities for CareLineLive with Accel-KKR. Hough acknowledged the critical contributions of prior investors Oakglen and Haatch, emphasizing the company's significant progress over the past decade.

Accel-KKR's investment strategy is heavily oriented towards enterprise software and tech-enabled businesses, and the firm highlighted CareLineLive’s dedication to customer-centric innovation as a pivotal reason for their investment. Maurice Hernandez, Managing Director at Accel-KKR, remarked that technology plays a vital role in empowering home care providers to enhance their services.

Hough emphasized that the senior management team, including himself, will remain with CareLineLive, maintaining continuity in the company's operations while leveraging new resources from Accel-KKR to explore further growth and innovations.

About CareLineLive
Founded in 2014, CareLineLive offers an innovative cloud-based platform specifically designed for homecare agencies, consolidating various essential functions like staff scheduling, patient visits, and invoicing. With its commitment to regulatory standards, it stands out as one of the few suppliers on the NHS's approved list for Digital Social Care Records, further integrating with GP Connect for seamless access to GP records.

About Accel-KKR
Accel-KKR is a leading technology investment firm boasting a substantial $21 billion in cumulative capital commitments. The firm focuses on partnerships with management teams to drive growth and add value within the software and tech-enabled sectors. With offices in major cities across the globe including Menlo Park, Atlanta, Chicago, London, and Mexico City, Accel-KKR is focused on middle-market companies, providing diverse capital solutions tailored to various investment types.

Frequently Asked Questions

What is the significance of the investment in CareLineLive?

The investment from Accel-KKR will enable CareLineLive to enhance growth, expand its international reach, and improve product development.

How does CareLineLive's platform benefit homecare agencies?

CareLineLive's platform streamlines operational tasks such as scheduling, client management, and invoicing, making it easier for agencies to provide efficient care.

Where does CareLineLive plan to establish customer support?

CareLineLive plans to set up a customer support presence in Australia, allowing for 24/7 service availability.

What is the market outlook for home healthcare?

The home healthcare market is rapidly growing, with substantial projections indicating strong potential for future expansion across several regions.

Who are the founders of CareLineLive?

Josh Hough is the founder of CareLineLive, which was established in 2014, and he continues to lead the company into its next phase of growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading